Suven Pharma Q2 profit rises 31% to ₹97 cr.
The Hindu
Suven Pharmaceuticals on Saturday posted a 31% increase in its consolidated net profit to ₹97 crore for the second quarter ended September 30. Revenue from operations rose to ₹301 crore for the quarte
Suven Pharmaceuticals on Saturday posted a 31% increase in its consolidated net profit to ₹97 crore for the second quarter ended September 30.
Revenue from operations rose to ₹301 crore for the quarter under review, as against ₹237 crore in the year-earlier period, Suven Pharmaceuticals said in a regulatory filing.
The COVID-19 pandemic continues to impact the business and research in India and its wholly owned subsidiary, Suven Pharma Inc. USA, it noted.
More Related News